IP Library › Granted Patent US 9,428,744
Granted Patent B2
US 9,428,744 · App. 14/308,526 · Granted Aug 30, 2016

Process for preparing a polymer/biological entities alloy

Inventors: Thierry Ferreira (Iteuil, FR); Frederic Bataille (Poitiers, FR); Cedric Dever (Poitiers, FR); Jacques Barbier (Poitiers, FR)
Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS; UNIVERSITE DE POITIERS; VALAGRO CARBONE RENOUVELABLE POITOU—CHARENTES
C12N11/08C08J3/005C08J3/201C08J3/203C08L67/04C12N9/14C12N9/20C12N9/58C12N11/04C12N11/18C08J2367/04C08K5/0033C08L2201/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,428,744
App. No.
14/308,526
Granted
Aug 30, 2016
Kind
B2
Abstract

The present invention relates to a process for preparing a polymer/biological entities alloy, comprising a step of mixing a polymer and biological entities that degrade it, during a heat treatment, said heat treatment being performed at a temperature T above room temperature and said biological entities being resistant to said temperature T, characterized in that said biological entities are chosen from enzymes that degrade said polymer and microorganisms that degrade said polymer.

Claims (10)

1. A process for preparing a polymer/biological entities alloy, comprising a step of mixing a polymer and biological entities, said biological entities degrade said polymer, wherein said alloy is prepared during a heat treatment performed at a temperature T above room temperature, at which the polymer is in a partially or totally molten state, said biological entities being able to degrade said polymer in said alloy, and wherein said polymer is polycaprolactone and said biological entity comprises a lipase.

2. The process as claimed in claim 1 , wherein said temperature T is between the glass transition temperature and the melting point of said polymer.

3. The process as claimed in claim 1 , wherein said temperature T is the melting point of said polymer.

4. The process as claimed in claim 1 , wherein said heat treatment consists of an operation chosen from extrusion, injection-molding, thermoforming, rotary molding, compression, calendering, ironing, coating, stratification, expansion, pultrusion, extrusion blow-molding, extrusion-swelling and compression-granulation.

5. The process as claimed in claim 4 , wherein said heat treatment consists of an extrusion operation.

6. The process as claimed in claim 1 , wherein the biological entities/polymer weight ratio is between about 0.1% and about 10%.

7. The process as claimed in claim 1 , wherein the biological entities/polymer weight ratio is about 2%.

8. The process as claimed in claim 1 , wherein the lipase is selected from the group consisting of lipase PS from Pseudomonas cepacia , lipase AK from Pseudomonas fluorescens , lipase B from Candida antarctica , and mixtures thereof.

9. The process as claimed in claim 1 , wherein said lipase is an amanolipases PS from Pseudomonas cepacia.

10. A polymer/biological entities alloy that may be obtained via the process as claimed in claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2014
From: ITEUIL, THIERRY; BATAILLE, FREDERIC; DEVER, CEDRIC; BARBIER, JACQUES
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS; UNIVERSITE DE POITIERS; VALAGRO CARBONE RENOUVELABLE POITOU-CHARENTES
Reel/Frame 033133/0089 →
Priority Claims (2)
FR 11 62045 · Dec 20, 2011 · national
FR 12 51852 · Feb 29, 2012 · national
Continuity (2)
Continuation In Part PCTFR2012053014 · Dec 20, 2012
Related Publication 20140303278A1 · Oct 9, 2014